非酒精性脂肪肝肝活检评估共识

2016-04-03 Minerva Gastroenterol Dietol. 2014 Mar;60(1):5-13.

非酒精性脂肪肝肝活检评估共识

中文标题:

非酒精性脂肪肝肝活检评估共识

英文标题:

Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease

发布机构:

发布日期:

2016-04-03

简要介绍:

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the United States. It is considered the hepatic manifestation of the metabolic syndrome. Approximately a third of adults in the United States have NAFLD. While the majority of individuals with NAFLD do not develop progressive liver disease and have been classified as having non-alcoholic fatty liver (NAFL), a subset of patients with NAFLD have the progressive form termed non-alcoholic steatohepatitis (NASH) that may progress to cirrhosis, and hepatocellular carcinoma. Liver biopsy evaluation is the gold standard for the detection of NASH. It is impractical, unnecessary and cost prohibitive to subject all patients with NAFLD to a liver biopsy evaluation. Here in this review, we discuss our approach to clinical risk stratification of patients with NAFLD and who should be referred for a liver biopsy based upon the likelihood of finding the presence of NASH and/or advanced fibrosis on liver biopsy.

相关资料下载:
[AttachmentFileName(sort=100, fileName=非酒精性脂肪肝肝活检评估共识)] GetToolGuiderByIdResponse(projectId=1, id=841791c0011590c0, title=非酒精性脂肪肝肝活检评估共识, enTitle=Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease, guiderFrom=Minerva Gastroenterol Dietol. 2014 Mar;60(1):5-13., authorId=null, author=, summary=非酒精性脂肪肝肝活检评估共识, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Apr 03 22:34:29 CST 2016, originalUrl=http://www.minervamedica.it/en/journals/gastroenterologica-dietologica/article.php?cod=R08Y2014N01A0005&acquista=1, linkOutUrl=, content=Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the United States. It is considered the hepatic manifestation of the metabolic syndrome. Approximately a third of adults in the United States have NAFLD. While the majority of individuals with NAFLD do not develop progressive liver disease and have been classified as having non-alcoholic fatty liver (NAFL), a subset of patients with NAFLD have the progressive form termed non-alcoholic steatohepatitis (NASH) that may progress to cirrhosis, and hepatocellular carcinoma. Liver biopsy evaluation is the gold standard for the detection of NASH. It is impractical, unnecessary and cost prohibitive to subject all patients with NAFLD to a liver biopsy evaluation. Here in this review, we discuss our approach to clinical risk stratification of patients with NAFLD and who should be referred for a liver biopsy based upon the likelihood of finding the presence of NASH and/or advanced fibrosis on liver biopsy.<br>, tagList=[TagDto(tagId=883, tagName=非酒精性脂肪肝)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3594, appHits=162, showAppHits=0, pcHits=2492, showPcHits=1258, likes=315, shares=6, comments=0, approvalStatus=1, publishedTime=Sun Apr 03 14:34:29 CST 2016, publishedTimeString=2016-04-03, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Sun Apr 03 14:34:29 CST 2016, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 12:05:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=非酒精性脂肪肝肝活检评估共识)])
非酒精性脂肪肝肝活检评估共识
下载请点击:
评论区 (0)
#插入话题